This inventor holds 2 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents. Top assignees: Piramal Enterprises Limited, Piramal Life Sciences Limited. Active years: 2011-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Maharashtra, IN (2011)
- Maharastra, IN (2013)
Company Filing History:
Years Active: 2011-2013
Title: Innovations of Manoj Shukla in Pharmaceutical Chemistry
Introduction
Manoj Shukla is a notable inventor based in Maharashtra, India, recognized for his contributions to pharmaceutical chemistry. He holds two patents that focus on innovative compounds for the treatment of proliferative disorders, particularly cancer. His work exemplifies the intersection of chemistry and medicine, aiming to provide effective solutions for serious health issues.
Latest Patents
Manoj Shukla's latest patents include significant advancements in the field of enantiomerically pure compounds. The first patent, titled "Enantiomerically pure compounds for the treatment of proliferative disorders," describes a (+)-trans enantiomer of a compound that is useful for treating diseases mediated by the inhibition of cyclin-dependent kinases, such as cancer. The invention also covers the processes for preparing these compounds and their pharmaceutical compositions.
The second patent, "Enantioselective synthesis of pyrrolidines substituted with flavones, and intermediates thereof," focuses on the enantioselective synthesis of pyrrolidines that act as inhibitors of cyclin-dependent kinases. This innovation is particularly relevant for the treatment of proliferative disorders, including various forms of cancer.
Career Highlights
Throughout his career, Manoj Shukla has worked with prominent companies in the pharmaceutical sector, including Piramal Enterprises Limited and Piramal Life Sciences Limited. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Manoj has collaborated with notable professionals in his field, including Meenakshi Sivakumar and Pramod Kumar Jadhav. These collaborations have likely enhanced his research and development efforts, leading to impactful inventions.
Conclusion
Manoj Shukla's contributions to pharmaceutical chemistry through his patents demonstrate his commitment to advancing medical science. His innovative approaches to treating proliferative disorders highlight the importance of research and development in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile